Prodrug of pyrrolidone derivatives as glucokinase activator
Abstract:
The present disclosure provides a compound of formula (I), or an isotopically labeled product, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof; a pharmaceutical composition comprising a compound of formula (I); and use of a compound of formula (I) or a pharmaceutical composition thereof in the treatment of diabetes mellitus and related symptoms.
Public/Granted literature
Information query
Patent Agency Ranking
0/0